Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Meet Genomic Prediction, which provides advanced genetic testing for IVF. They have developed a novel, genome-wide molecular genotyping methodology for preimplantation genetic testing of embryos.

Dr. Nathan Treff, Chief Scientific Officer at Genomic Prediction, joins us to discuss the cutting-edge technology that offers IVF parents and families a cost-effective means to evaluate genetic risks due to chromosomal abnormalities, single-gene disorders, and multi-gene disorders, known as polygenic diseases such as diabetes, cancer, and heart disease.

Their approach provides an unparalleled level of options for identifying potential disease risk in embryos and improving newborn health outcomes.

For Genomic Prediction, it’s about helping IVF parents be more knowledgeable, showing them the risks and providing options to help make the best and most informed decisions for their families.

Don’t move! The Balancing Act is back with a new Behind the Mystery segment and an inside look at a Broadway sensation.

We're discussing Alport syndrome, a rare, genetic, and chronic kidney condition characterized by declining kidney function which can lead to end-stage kidney disease.

When it comes to facial and body rejuvenation, discover a patient-first, non-surgical approach at Jupiter Plastic Surgery Center.

Comments

comments